@Article{ecn.2019.0436,
AUTHOR = {Gautier Breville, Agustina M. Lascano, Pascale Roux-Lombard, Patrice H. Lalive},
TITLE = {IL-8 as a potential biomarker in Guillain-Barre Syndrome},
JOURNAL = {European Cytokine Network},
VOLUME = {30},
YEAR = {2019},
NUMBER = {4},
PAGES = {130--134},
URL = {http://www.techscience.com/ECN/v30n4/65383},
ISSN = {1952-4005},
ABSTRACT = {This pilot study was designed to compare the levels of interleukin-8 (IL-8), a pro-inflammatory
chemokine, in the cerebrospinal fluid (CSF) of patients with Guillain-Barre syndrome (GBS), chronic inflammatory
demyelinating polyneuropathy (CIDP), non-inflammatory polyneuropathy (PNP), and other non-inflammatory
neurological diseases (functional syndrome or migraine). The results show elevated CSF IL-8 levels in GBS compared
to the other groups (p < 0.05). IL-8 could be considered a potential biomarker to differentiate GBS from CIDP. This
distinction could be relevant in terms of therapeutic decisions and functional prognosis.},
DOI = {10.1684/ecn.2019.0436}
}